Cynosure Lutronic sets stage for global Mosaic 3D rollout with IMCAS 2026 momentum
Find out how Cynosure Lutronic’s Mosaic 3D laser device could redefine non-ablative resurfacing after CE mark approval under EU MDR.
Medical Devices & Diagnostics
Pharma & Biotech
How Galderma’s Wake Up To Restylane campaign reflects evolving aesthetics patient preferences
Explore how Galderma’s Wake Up To Restylane strategy and new IMCAS data could reshape aesthetic practice and hyaluronic acid filler adoption.